SCHEMBL1196180

SCHEMBL1196180

CC(=O)Nc1cccc2nc3cc(N)ccc3cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.49
MEN1 O00255 6/20 0.49
KDM4E B2RXH2 7/20 0.47
MAPT P10636 7/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
GLA P06280 1/20 0.47
TNNI3 P19429 1/20 0.47
TNNT2 P45379 1/20 0.47
TNNC1 P63316 1/20 0.47
RUNX1 Q01196 1/20 0.47
CBFB Q13951 1/20 0.47
HTR3A P46098 1/20 0.46
CLK1 P49759 2/20 0.46
LMNA P02545 3/20 0.45
F2 P00734 1/20 0.45
CHRM2 P08172 1/20 0.45
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
ADORA3 P0DMS8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17066283 0.80 HTR3A (0.54) KMT2AMEN1KDM4EMAPTNPC1
Proflavine SCHEMBL28425236 0.76 KMT2A (0.72) KMT2AMEN1KDM4EMAPTNPC1
SCHEMBL29384128 0.76 KDM4E (0.81) KMT2AMEN1KDM4EMAPTNPC1
SCHEMBL125080 0.76 KDM4E (0.81) KMT2AMEN1KDM4EMAPTNPC1
SCHEMBL8628036 0.73 KMT2A (0.70) KMT2AMEN1KDM4EMAPTNPC1
SCHEMBL28647309 0.73 MEN1 (0.60) KMT2AMEN1KDM4EMAPTNPC1
SCHEMBL4149685 0.72 KMT2A (0.51) KMT2AMEN1KDM4EMAPTNPC1
Hydrochloric Acid SCHEMBL28888962 0.71 KMT2A (0.68) KMT2AMEN1KDM4EMAPTNPC1
SCHEMBL4821314 0.71 MEN1 (0.60) KMT2AMEN1KDM4EMAPTNPC1
SCHEMBL5187383 0.70 IDO1 (0.51) KMT2AKDM4EMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109313199-A The method for preparing sugar chain 住友电木株式会社 2019-02-05 CN disclosed
US-20110046364-A1 METHOD OF LABELING SUGAR CHAIN SUMITOMO BAKELITE CO., LTD. (JP) 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046364-A1 METHOD OF LABELING SUGAR CHAIN SLC2A2, FUT6, SLC2A1 KMT2A 2528/4885MEN1 3316/4885KDM4E 2891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.